Kythera Biopharmaceuticals Analysis

Kythera Biopharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Kythera Biopharmaceutica delisted stock analysis is to determine its intrinsic value, which is an estimate of what Kythera Biopharmaceuticals is worth, separate from its market price. There are two main types of Kythera Biopharmaceutica's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Kythera Biopharmaceutica's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Kythera Biopharmaceutica's stock to identify patterns and trends that may indicate its future price movements.
The Kythera Biopharmaceutica stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Kythera Biopharmaceutica is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Kythera Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Kythera Biopharmaceutica's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Kythera Stock Analysis Notes

About 36.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 4.77. Kythera Biopharmaceutica had not issued any dividends in recent years. KYTHERA Biopharmaceuticals, Inc., a clinicalstage biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription solutions for the aesthetic medicine market in the United States and internationally. To find out more about Kythera Biopharmaceuticals contact the company at 818-587-4500 or learn more at http://www.kytherabiopharma.com.

Kythera Biopharmaceutica Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Kythera Biopharmaceutica's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Kythera Biopharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Kythera Biopharmaceutica is not yet fully synchronised with the market data
Kythera Biopharmaceutica has some characteristics of a very speculative penny stock
Kythera Biopharmaceutica has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 288 K. Net Loss for the year was (112.66 M) with profit before overhead, payroll, taxes, and interest of 17.75 M.
Kythera Biopharmaceuticals currently holds about 184.85 M in cash with (77.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.04.
Over 82.0% of the company shares are owned by institutional investors

Kythera Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.97 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kythera Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Kythera Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Kythera Profitablity

Kythera Biopharmaceutica's profitability indicators refer to fundamental financial ratios that showcase Kythera Biopharmaceutica's ability to generate income relative to its revenue or operating costs. If, let's say, Kythera Biopharmaceutica is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Kythera Biopharmaceutica's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Kythera Biopharmaceutica's profitability requires more research than a typical breakdown of Kythera Biopharmaceutica's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (247.94) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.84) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.84.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Kythera Biopharmaceutica to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in Kythera Stock

If you are still planning to invest in Kythera Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kythera Biopharmaceutica's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges